Important Innovations

Moderna New Vaccine Goes to National Institutes of Health Source:  Novel Coronavirus Ready for Phase One Human Trials While the deadly Coronavirus continues to take its toll globally, a new vaccine offering hope for prevention is on its way to the NIH in Washington, DC.  This is the first Coronavirus vaccine going into clinical trials by the NIH.  Moderna, a biotech company specializing in vaccines & headquartered in Cambridge, MA, has invented what it calls  the mRNA-1273 vaccine to prevent the Coronavirus infection.  The NIH is going to begin Phase 1 trials for human use.  Turnaround time and availability could be within a year Overnight Share Price Lift Moderna announced that it was shipping the vaccine to the NIH last night.  The company is publicly traded on the NASDAQ.  In overnight trading, Moderna shares were up 15% on the news.  Over the past few years, the company has created more than 100 vaccines and therapies for clinical trials. Fear of the Coronav

Augmented Reality's 3 Dimensional Precision Source:  AR Tech in the Operating Room AR Goggles in the OR AR is a technology that superimposes computer generated information on the user's view of the real world.  It's being tested at Beth Israel Deaconess Medical Center in Boston.  And it seems to greatly help surgeons visualize complex medical data particularly during heart surgery. Surgeons with AR Goggles A new self-contained AR device provides surgeons with the opportunity to interactively explore data in 3 D and real time during complex surgical procedures.  Here's how it works.  The surgeon wears  AR goggles that are similar to the glass screens worn by divers.  The AR images are projected onto the surgeon's facial screen to augment their view and vital information on their patient during complex surgical procedures.. NIH Funded Successful Test Pilot Program This is a pilot program and has been used successfully on 5 animal models.  The program is